Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Eyepoint Pharmaceuticals Inc (NQ: EYPT )

11.46 USD -0.26 (-2.22%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 27, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 88,159
Open 11.74
Bid (Size) 11.46 (2)
Ask (Size) 11.53 (8)
Prev. Close 11.72
Today's Range 11.44 - 12.01
52wk Range 3.511 - 15.06
Shares Outstanding 28,770,033
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
EyePoint Pharmaceuticals to Present Data at the American Academy of Ophthalmology (AAO) 2021 Annual Meeting
From GlobeNewswire News Releases
EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences
From GlobeNewswire News Releases

Performance

YTD
+27.19%
+27.19%
1 Month
+13.92%
+13.92%
3 Month
+29.35%
+29.35%
6 Month
+23.23%
+23.23%
1 Year
+116.23%
+116.23%

More News

Read More
EyePoint Pharmaceuticals to Present at the H.C. Wainwright Ophthalmology Virtual Conference
From GlobeNewswire News Releases
EyePoint Pharmaceuticals Reports Second Quarter 2021 Financial Results and Highlights Recent Corporate Developments
From GlobeNewswire News Releases
EyePoint Pharmaceuticals Announces Renowned Scientists to Join New Executive Scientific Advisory Board
From GlobeNewswire News Releases
EyePoint Pharmaceuticals to Report Second Quarter 2021 Financial Results on August 4, 2021
From GlobeNewswire News Releases
EyePoint Pharmaceuticals Receives Preliminary Extension to Pass-Through Payment Status for DEXYCU®
From GlobeNewswire News Releases
EyePoint Pharmaceuticals Reports Positive 30-day Safety Results for all Cohorts from the DAVIO Trial of EYP-1901 for wet-AMD
From GlobeNewswire News Releases
EyePoint Pharmaceuticals Announces New Category III CPT Code for DEXYCU® Intraocular Suspension, Approved by the American Medical Association
From GlobeNewswire News Releases
EyePoint Pharmaceuticals Joins Russell 2000® and Russell 3000® Index
From GlobeNewswire News Releases
EyePoint Pharmaceuticals to Participate in Fireside Chat at the Jefferies Virtual Healthcare Conference
From GlobeNewswire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.